Article
Refine
Year of publication
- 2024 (28)
- 2023 (52)
- 2022 (81)
- 2021 (90)
- 2020 (127)
- 2019 (118)
- 2018 (125)
- 2017 (108)
- 2016 (113)
- 2015 (125)
- 2014 (138)
- 2013 (138)
- 2012 (129)
- 2011 (178)
- 2010 (177)
- 2009 (197)
- 2008 (179)
- 2007 (170)
- 2006 (178)
- 2005 (182)
- 2004 (207)
- 2003 (147)
- 2002 (166)
- 2001 (154)
- 2000 (168)
- 1999 (153)
- 1998 (164)
- 1997 (151)
- 1996 (139)
- 1995 (147)
- 1994 (135)
- 1993 (107)
- 1992 (102)
- 1991 (74)
- 1990 (82)
- 1989 (79)
- 1988 (79)
- 1987 (77)
- 1986 (65)
- 1985 (59)
- 1984 (56)
- 1983 (47)
- 1982 (38)
- 1981 (39)
- 1980 (50)
- 1979 (43)
- 1978 (41)
- 1977 (22)
- 1976 (25)
- 1975 (18)
- 1974 (13)
- 1973 (6)
- 1972 (15)
- 1971 (7)
- 1970 (2)
- 1968 (2)
- 1967 (1)
Institute
- Fachbereich Medizintechnik und Technomathematik (1542)
- Fachbereich Wirtschaftswissenschaften (700)
- Fachbereich Elektrotechnik und Informationstechnik (629)
- Fachbereich Energietechnik (598)
- Fachbereich Chemie und Biotechnologie (588)
- INB - Institut für Nano- und Biotechnologien (524)
- Fachbereich Maschinenbau und Mechatronik (463)
- IfB - Institut für Bioengineering (426)
- Fachbereich Luft- und Raumfahrttechnik (367)
- Fachbereich Bauingenieurwesen (327)
Has Fulltext
- no (5513) (remove)
Language
Document Type
- Article (5513) (remove)
Keywords
- avalanche (5)
- Earthquake (4)
- LAPS (4)
- field-effect sensor (4)
- frequency mixing magnetic detection (4)
- CellDrum (3)
- Heparin (3)
- capacitive field-effect sensor (3)
- hydrogen peroxide (3)
- impedance spectroscopy (3)
After a liver tumor intervention the medical doctor has to compare both pre and postoperative CT acquisitions to ensure that all carcinogenic cells are destroyed. A correct assessment of the intervention is of vital importance, since it will reduce the probability of tumor recurrence. Some methods have been proposed to support the medical doctors during the assessment process, however, all of them focus on secondary tumors. In this paper a tool is presented that enables the outcome validation for both primary and secondary tumors. Therefore, a multiphase registration (preoperative arterial and portal phases) followed by a registration between the pre and postoperative CT images is carried out. The first registration is in charge of the primary tumors that are only visible in the arterial phase. The secondary tumors will be incorporated in the second registration step. Finally, the part of the tumor that was not covered by the necrosis is quantified and visualized. The method has been tested in 9 patients, with an average registration error of 1.41 mm.
This Research Briefing, issued in July 2010, concluded that:
- Small and medium-sized enterprises (SMEs) in Europe have long called for a matching legal form valid across the EU (similar to that of the European company (SE) for large firms)
- The main benefits would be the availability of uniform Europe-wide company structures, significant cost reductions for businesses and further integration of the internal market
- Given the differing national views regarding the concrete features of the new legal form there is currently no sign of an agreement being reached at the European level in the short term; however, it is possible that progress will be made in negotiations during the year
- The key issues being discussed in depth are company formation, transnationality and employee participation rights in the new European private company (SPE).